Open Access
The use of drug monitoring of infliximab and adalimumab to optimize the treatment of inflammatory bowel diseases in children
Author(s) -
Т. В. Радыгина,
A Illarionov,
С. В. Петричук,
Д. Г. Купцова,
O. V. Kurbatova,
Аndrey P. Fisenko,
А. С. Потапов,
Е.Л. Семикина,
A.O. Anushenko
Publication year - 2022
Publication title -
rossijskij pediatričeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2413-2918
pISSN - 1560-9561
DOI - 10.46563/1560-9561-2022-25-5-313-320
Subject(s) - medicine , infliximab , adalimumab , exacerbation , therapeutic drug monitoring , drug , inflammatory bowel disease , gastroenterology , pharmacokinetics , tumor necrosis factor alpha , pharmacology , disease